2025-04-11 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**0) Executive Summary:**

Colgate-Palmolive Co (CL) is a leading global consumer goods company specializing in oral hygiene, personal care, and home care products.  This report analyzes CL's performance against the S&P 500 (VOO), examining its recent financial results, valuation metrics, and risk indicators to assess its investment potential.

**1) Performance Comparison with S&P 500:**

Colgate-Palmolive's cumulative return is significantly lower than the S&P 500's.

* **CL Cumulative Return:** 27.26%
* **VOO (S&P 500) Cumulative Return:** 65.78%
* **Return Difference:** -38.5%
* **Relative Divergence:** 36.4% (This indicates CL's underperformance relative to the S&P 500 falls within the lower 36.4% of its historical range of divergence, based on the provided min and max values.)


The provided CAGR data shows varying performance over different periods, with some periods outperforming the market and others underperforming significantly. Alpha values suggest periods of both outperformance and underperformance relative to the market beta, indicating inconsistent market-beating abilities.  Beta values consistently demonstrate a moderate sensitivity to the overall market.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.8% | -16.0% | 0.1 | 51.5 |
| 2016-2018  | -11.0% | 65.2% | -29.0% | 0.1 | 41.6 |
| 2017-2019  | 7.0% | 65.2% | -22.0% | 0.2 | 49.4 |
| 2018-2020  | 18.0% | 65.2% | -8.0% | 0.7 | 62.8 |
| 2019-2021  | 30.0% | 58.6% | -25.0% | 1.0 | 64.1 |
| 2020-2022  | 8.0% | 68.9% | 1.0% | 1.0 | 60.6 |
| 2021-2023  | 5.0% | 68.9% | -12.0% | 0.9 | 62.9 |
| 2022-2024  | 12.0% | 68.9% | -5.0% | 0.8 | 73.3 |
| 2023-2025  | 14.0% | 79.8% | 0.0% | 0.3 | 74.5 |


**2) Recent Price Movement:**

* **Closing Price:** $91.80
* **5-Day Moving Average:** $90.30
* **20-Day Moving Average:** $91.41
* **60-Day Moving Average:** $90.03

The price is slightly above both the 5-day and 20-day moving averages, and above the 60-day moving average, suggesting a relatively positive short-term trend.  The recent price change of $1.74 (from $90.23) indicates a mild upward movement.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4292 (Medium Risk)
* **RSI:** 53.68 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** -0.33 (Negative, suggesting bearish momentum)
* **20-Day Relative Divergence Change:** -13.9% (Short-term downward trend)
* **Expected Return:** -63.3% (This indicates a significant expected underperformance relative to the S&P 500 over the long term (2+ years), based on current data.)


**4) Recent Earnings Analysis:**

The earnings data shows relatively stable revenue around $5 billion, with slight fluctuations. EPS also shows minor variations but remains consistent.  Further analysis is needed to assess the impact of these variations on profitability and overall business performance.


| 날짜 | EPS | 매출 |
|---|---|---|
| 2024-10-25 | 0.9 | 5.03 B$ |
| 2024-07-26 | 0.89 | 5.06 B$ |
| 2024-04-26 | 0.83 | 5.07 B$ |
| 2023-10-27 | 0.86 | 4.92 B$ |
| 2024-10-25 | 0.86 | 4.92 B$ | *(Note: Duplicate entry – possible data entry error)*


**5) Financial Information:**

Revenue has remained relatively stable, with profit margins consistently high (around 60%). However, the Equity and ROE figures show significant volatility quarter over quarter, requiring further investigation to understand the underlying causes. High ROE values could be a positive indicator of strong profitability, but the fluctuations raise concerns about the stability of the financial performance.  Further analysis is needed to ascertain if these fluctuations are due to temporary factors or if this volatility is a consistent pattern.


| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $0.21B | 348.58% |
| 2024-09-30 | $0.43B | 169.43% |
| 2024-06-30 | $0.12B | 594.31% |
| 2024-03-31 | $0.23B | 296.96% |
| 2023-12-31 | $0.61B | 117.90% |


**6) Overall Analysis:**

Colgate-Palmolive (CL) shows a mixed performance picture. While it boasts high and consistent profit margins and stable revenue, its significantly lower returns compared to the S&P 500 and a negative expected return relative to the market raise concerns.  The volatility in ROE and equity figures necessitates further investigation.  The relatively positive short-term price trend should be viewed cautiously given the overall underperformance against the market and the negative expected return. Before making any investment decisions, a deeper dive into the underlying factors influencing the financial metrics and a comprehensive risk assessment are crucial.  Additional information on debt levels, competition, and future growth prospects would provide a more complete picture.
